Pharmed Pharmaceutical Pty Ltd has sold a 65% stake to Imperial Holdings Limited
Lenmed Health Pty Ltd has sold a 65% stake in Pharmed Pharmaceutical Pty Ltd to Imperial Holdings Limited for US$10 million.
Pharmed Pharmaceutical Pty Ltd distributes pharmaceutical and other healthcare products in South Africa. The company was founded in 1985 in Overport, Durban by a group of healthcare professionals from previously disadvantaged communities.
Imperial Holdings Limited is a JSE-listed, South African-based international group of companies active in three major areas of mobility: consumer and industrial logistics, vehicle import, distribution, dealerships, retail, rental and aftermarket parts and vehicle-related financial services. The company employs around 52,000 people who generate revenues in excess of US$7.5 billion per year in Africa, Europe, South America, Australia and the USA through five major divisions which operate under separate management structures to enable decentralized entrepreneurial creativity within the group’s clearly defined strategic, capital, budgetary and governance principles.
Lenmed Health is an established black owned hospital group in South Africa, operating multi-specialty hospital facilities in South Africa, Mozambique and Botswana and managing in excess of 1,300 beds.
Oaklins' team in South Africa advised the seller in this transaction.
Talk to the deal team
Related deals
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moreAfric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more